Increased volume has led to stress among endovascular stroke physicians, with some hospitals relying on interventional rads to relieve the strain. 

The REDUCE LAP-HF II study identified heart failure patients who may benefit from receiving a new transcatheter implant manufactured by Corvia Medical.

Daily acetaminophen use was associated with a “significant increase” in daytime systolic and diastolic blood pressure.

A key takeaway from the group's analysis was that the rate of major bleeding events did not significantly change. 

TAVR-related stroke, the authors wrote, is a "critically important and potentially preventable source of patient morbidity."

Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues.

Evidence shows this technology has the potential to improve care for vulnerable patients with cardiovascular disease.

Researchers focused on data from two previous trials to track the impact of IVUS guidance on mortality rates and other key outcomes after three years. 

The investigational dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart.

There have been no incidents at this time, but the device is similar to another Medtronic solution that was recently recalled.